TABLE 3

Relative risk of developing type 2 diabetes during the trial period according to tertiles of change in LTPA

Model 1Model 2Model 3
Change in total LTPA
    −3.2 (−35 to −0.5)111
    0.5 (−0.5 to 1.7)0.47 (0.28–0.79)0.48 (0.28–0.82)0.52 (0.31–0.89)
    3.8 (1.8–19)0.26 (0.15–0.47)0.29 (0.16–0.53)0.34 (0.19–0.62)
    P for trend<0.001<0.001<0.001
Change in moderate-to-vigorous LTPA (≥3.5 METs)
    −1.5 (−13.5 to −0.1)111
    0.5 (−0.1 to 1.3)0.78 (0.46–1.33)0.86 (0.49–1.48)0.95 (0.54–1.65)
    2.6 (1.3–14.4)0.35 (0.18–0.65)0.40 (0.21–0.76)0.51 (0.26–0.97)
    P for trend0.0010.0040.037
Change in low-intensity LTPA (<3.5 METs)
    −3.2 (−34 to −1.0)111
    0.1 (−0.9 to 1.1)0.83 (0.47–1.45)0.85 (0.47–1.53)0.63 (0.34–1.17)
    3.1 (1.1–15.0)0.38 (0.20–0.70)0.41 (0.22–0.77)0.36 (0.19–0.67)
    P for trend0.0010.0030.001
  • Data are relative risk (95% CI). LTPA data represent hours per week. Model 2: Adjusted variables in model 1 and baseline values and changes in dietary intake of energy, total fat, saturated fat, and fiber. Model 3: Adjusted for variables in model 2 and baseline values and changes in BMI.